ASX Company Webcasts
Far East Gold (ASX: FEG) Company Q&A
In this session Far East Gold’s Non-Executive Chairman Justin Werner details of the strategic investment by Xingye, targeting over A$14 million for a 19.99% stake.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed the significance of Felix’s exceptional high-grade antimony assay results and the potential of near-term low capex production, including collaboration with relevant U.S. government agencies.
Far East Gold (ASX: FEG) Webcast Replay
In this session Far East Gold’s newly appointed Non-Executive Chairman Justin Werner discussed what the potentially transformative Idenburg acquisition could mean for Far East Gold.
Far East Gold (ASX: FEG) Investor Q&A
In this session Far East Gold’s CEO and Director Shane Menere and newly appointed Non-Executive Chairman Justin Werner discussed what the potentially transformative Idenburg acquisition could mean for Far East Gold.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed their plans to grow and develop NW Array’s 467koz resource.
18
Apr
Far East Gold (ASX: FEG) Webcast Replay
In this session Far East Gold’s CEO and Director Shane Menere discussed the standout assays from our Woyla drilling campaigns that form the base of our upcoming maiden JORC resource publication.
Prescient Therapeutics (ASX: PTX) Webcast Replay
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.
Pitt Street Research on Prescient Therapeutics
Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.
Far East Gold (ASX: FEG) Webcast Replay
In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……
Propell Holdings (ASX: PHL) Webcast Replay
In this session Propell CEO Michael Davidson discussed Propell’s recent progress on the platform, cost base, and establishing a broker network…
19
Dec
Site Group (ASX: SIT) Webcast Replay
In this session International Operations Director of Site Group, Vernon Wills discussed Site’s recent contract wins, growth opportunities and the key catalysts ahead.
Prescient Therapeutics (ASX: PTX) Webcast Replay
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed the new PTX-100 Phase 1b clinical study results, following their unveiling at the American Society of Hematology (ASH) conference.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.